Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2018

Apr 30, 2018

31949_dirs_2018-04-30_9f5e5076-349d-4f89-a01f-8bc3e3ab84b0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-04-26

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-04-26 Ordinary Shares M 20000 $3.44 Acquired 166558 Direct
2018-04-26 Ordinary Shares S 13572 $26.00 Disposed 152986 Direct
2018-04-26 Ordinary Shares S 1800 $26.01 Disposed 151186 Direct
2018-04-26 Ordinary Shares S 4300 $26.025 Disposed 146886 Direct
2018-04-26 Ordinary Shares S 328 $26.05 Disposed 146558 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-04-26 Options to Buy Ordinary Shares $3.44 M 20000 Disposed 2021-12-13 Ordinary Shares (20000) Direct

Footnotes

F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.

F2: Fully vested as of the date hereof.